Kerri Fitzgerald

Kerri Fitzgerald

Articles by Kerri Fitzgerald

Kerri FitzgeraldISGIO 2023 | March 19, 2025
While liver cancer is the third deadliest cancer in the world, there are still unmet needs regarding the disease.
Read More
Kerri FitzgeraldBile Duct Cancer | April 22, 2020
The U.S. Food and Drug Administration approved Pemazyre™ (pemigatinib), the first targeted treatment for adults with ...
Kerri FitzgeraldColorectal Cancer | March 19, 2025
The U.S. Food and Drug Administration (FDA) approved Braftovi® (encorafenib) in combination with cetuximab for ...
Kerri FitzgeraldLiver Cancer | March 19, 2025
The U.S. Food and Drug Administration approved Opdivo® (nivolumab) in combination with Yervoy® (ipilimumab) for ...
Kerri FitzgeraldColorectal Cancer | February 11, 2020
In patients with atrial fibrillation (AF) who receive anticoagulants, lower gastrointestinal (GI) bleeding is associated ...
Kerri FitzgeraldGastric Cancer | March 19, 2025
Patients with Helicobacter pylori (H. pylori) infection and a first-degree family history of gastric cancer had a ...
Kerri FitzgeraldColorectal Cancer | January 29, 2020
A study found that the oral bacterium Fusobacterium nucleatum (F. nuc) presents in a greater number of colorectal ...
Kerri FitzgeraldGastric Cancer | March 19, 2025
The U.S. Food and Drug Administration approved Ayvakit™ (avapritinib) for adults with unresectable or metastatic ...
Kerri FitzgeraldColorectal Cancer | March 19, 2025
Reducing the recommended screening age for colorectal cancer (CRC) has increased screening adherence in patients aged 45 ...
Kerri FitzgeraldColorectal Cancer | March 19, 2025
The dependent coverage expansion provision under the Affordable Care Act (ACA) has led to earlier diagnosis and better ...
Kerri FitzgeraldPancreatic Cancer | March 19, 2025
A large study spanning 195 countries found that colorectal and pancreatic cancer rates have increased by 10% between ...
Kerri FitzgeraldColorectal Cancer | March 19, 2025
Patients with colorectal cancer (CRC) who present with no alarming symptoms may encounter a longer time to referral of a ...
Kerri FitzgeraldPancreatic Cancer | March 19, 2025
The addition of cisplatin to Abraxane® (nab-paclitaxel) and Gemzar® (gemcitabine) improved survival in patients with ...
Kerri FitzgeraldColorectal Cancer | October 8, 2019
Circulating tumor DNA detected through liquid biopsy is an independent predictor of patients with colorectal cancer ...
Kerri FitzgeraldPancreatic Cancer | March 19, 2025
A study published in Nature found that the movement of certain fungi from the gut to the pancreas can increase the risk ...
Kerri FitzgeraldEsophageal Cancer | March 19, 2025
Results from the multicenter, randomized, open-label, global, phase III ATTRACTION-3 trial presented at the ESMO ...
Kerri FitzgeraldColorectal Cancer | September 12, 2019
Patients with metastatic colorectal cancer (CRC) harboring a subset of non-V600 mutations in the BRAF gene were more ...
Kerri FitzgeraldColorectal Cancer | March 19, 2025
The incidence of colorectal cancer (CRC) has increased in young adults in nine high-income countries spanning three ...
Kerri FitzgeraldPancreatic Cancer | March 19, 2025
Patients with type 2 diabetes who are treated with dipeptidyl peptidase-4 (DPP-4) inhibitors are at risk for developing ...
Kerri FitzgeraldColorectal Cancer | August 28, 2019
A text message reminder one week prior to a scheduled colonoscopy significantly decreased the number of patients who did ...